Skip to main content

Now live! Explore the program for the upcoming 2024 Global Conference, taking place May 5-8, 2024.

Sandrine Miller-Montgomery

< Back to previous page

Sandrine Miller-Montgomery

Co-Founder, Board Member, President and CEO, Micronoma Inc.
Sandrine Miller-Montgomery

Sandrine Miller-Montgomery, Pharm.D., Ph.D. is the Co-Founder, President and CEO of Micronoma, the first cancer-detection company using liquid biopsy technology to detect and predict cancer by analyzing the microbial signal with clinical-grade accuracy at an early stage of the disease. Prior to this, she was executive director of UC San Diego’s Center for Microbiome Innovation (CMI) that she co-led with renowned microbiome researcher, Dr. Rob Knight. There, she established a world-class team focused on expanding industry and academic collaborations in the field of microbiome research that resulted in raising more than $20M of financial support through key partnerships toward application of this science to AI, diet and nutrition, aging, environment, human disease understanding and more. Before this three-year detour in academia, she worked in large biotech and multinational companies in the life science industry, as well as start-ups. She has assumed different responsibilities from R&D director to leading sales and marketing organizations. She excels at preparing companies for successful exits as shown by her work at Helixis, acquired by Illumina, and MO BIO Labs acquired by QIAGEN. A scientist at heart and with a drive to bring life-changing innovation to the masses, Sandrine has found her passion in leading Micronoma, committed to improving the lives of all involved in cancer diagnosis.